Apyx Medical (APYX) Non-Current Deffered Revenue (2014 - 2026)

Apyx Medical (APYX) has reported Non-Current Deffered Revenue for 12 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Non-Current Deffered Revenue fell 5.03% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $1.1 million (down 5.03% YoY), and the FY2025 full-year result was $1.0 million, down 6.08% from the prior year.
• Non-Current Deffered Revenue held at $1.1 million in Q2 2026 per APYX's latest filing, from $1.1 million in the prior quarter.
• Across five years, Non-Current Deffered Revenue topped out at $1.4 million in Q4 2022 and bottomed at $1.0 million in Q4 2025.
• Historically, Non-Current Deffered Revenue has averaged $1.2 million across 5 years, with a median of $1.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Non-Current Deffered Revenue soared 62.11% in 2022, then retreated 11.51% in 2023.
• Over 5 years, Non-Current Deffered Revenue stood at $1.4 million in 2022, then dropped by 11.51% to $1.2 million in 2023, then decreased by 10.27% to $1.1 million in 2024, then dropped by 6.08% to $1.0 million in 2025, then grew by 8.0% to $1.1 million in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $1.1 million, $1.1 million, and $1.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.